This cross-sectional study aimed to evaluate the post-vaccination complications of vaccines on the people around the setting of JPMC, Karachi, in Pakistan, and compare the complications of the first and second doses of COVID-19 vaccines, conducted from May 2021 to June 2022. Only vaccinated people participated in the study. We collected the data through questionnaires and by interacting with the participants. Data was analyzed through SPSS version 21 with a 95% confidence interval and significance level (p < 0.05). The total number of participants was 325, aged between 20 to 70. About 55.7% of the participants were female, while 44% were male. 28% of the participants got positive COVID tests in the past. 48.9% were medical students, 19.1% were doctors, 2.5% were pharmacists, 0.3% were nurses, and 29.2% were of other professions. About 40.3% of the participants got Sinopharm, 33% got Sinovac, 5% got Moderna, 16% got Pfizer, 4.3% got AstraZeneca, and 1.5% got Sputnik V. About 57.9% experienced minor complications after the first dose of the vaccine, and 48.3% experienced minor complications after the second dose. Among these complications, headache, fatigue, and muscle ache were statistically significant, with p-values of 0.020, 0.000, and 0.042, respectively. The study inferred that no significant health complications were reported in participants after both doses of COVID-19 vaccination, and there is a low risk of adverse effects after COVID-19 vaccination.